Analysis of Rituximab for membranous nephropathy
by admin ~ February 16th, 2010.
A drug that is currently used to treat varying severe health complications can be used to treat membranous nephropathy.
Rituximab, the drug, may prove effective for providing relief to patients suffering from membranous nephropathy. This finding appeared in the April 2009 print issue of the Clinical Journal of the American Society of Nephrology (CJASN).
From News-Medical.Net:
To investigate rituximab’s potential, Andrew Bomback, MD (University of North Carolina Kidney Center), and his colleagues conducted the first systematic review of rituximab use in patients with membranous nephropathy. They collected and analyzed all of the data available on rituximab therapy in this patient population. They found 21 articles to date, all of which were either case reports or case series without controls, meaning that patients taking rituximab were studied for a certain length of time but were not compared with patients not taking the drug.
Dr. Bomback said that future studies are needed to confirm the value of this drug. Till that time, the use of Rituximab for membranous nephropathy must be done only in research settings.
Category: Anabolic Steroids | Tags: membranous nephropathy, Rituximab, steroids